Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-01 OYLER JOHN Chief Executive Officer Sale −2,859 $140.96 $403K 474
2020-05-01 OYLER JOHN Chief Executive Officer Sale −474 $141.00 $67K 0
2020-05-01 Wu Xiaobin President & GM China Sale −5,255 $140.96 $741K 1,769
2020-05-01 Wu Xiaobin President & GM China Sale −1,224 $142.54 $174K 545
2020-05-01 Wu Xiaobin President & GM China Sale −300 $143.17 $43K 245
2020-05-01 Wu Xiaobin President & GM China Sale −245 $141.00 $35K 0
2020-04-29 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-04-29 Huang Jane CMO, Hematology Sale −1,500 $162.30 $243K 0
2020-04-29 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 500,075
2020-04-16 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-04-16 Huang Jane CMO, Hematology Sale −1,500 $160.00 $240K 0
2020-04-16 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 519,575
2020-03-04 Wang Xiaodong Director Sale −3,031 $156.82 $475K 1,969
2020-03-04 Wang Xiaodong Director Sale −1,768 $157.51 $278K 201
2020-03-04 Wang Xiaodong Director Sale −201 $158.63 $32K 0
2020-03-03 HOOPER ANTHONY C Director Grant or award · Share Option (Right to Buy) +21,970 21,970
2020-02-18 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-02-18 Huang Jane CMO, Hematology Sale −1,179 $170.01 $200K 321
2020-02-18 Huang Jane CMO, Hematology Sale −321 $171.14 $55K 0
2020-02-18 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 539,075

Page 95 of 99 · 1,972 trades